Clinical Trial Update: AGE Levels in ER+ Metastatic Breast Cancer Patients Receiving Endocrine Therapy [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating AGE levels in estrogen receptor-positive metastatic breast cancer patients receiving endocrine therapy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Medical University of South Carolina | Conditions: Breast Cancer | Phase 1 | Status: TERMINATED